REPRESENTATIVENESS OF THE SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM DATA - RECENT TRENDS IN CANCER MORTALITY-RATES

被引:86
|
作者
FREY, CM
MCMILLEN, MM
COWAN, CD
HORM, JW
KESSLER, LG
机构
[1] OPIN RES CORP,WASHINGTON,DC
[2] NATL CTR HLTH STAT,HYATTSVILLE,MD 20782
关键词
D O I
10.1093/jnci/84.11.872
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Mortality, incidence, and survival rates are the primary measures used by the National Cancer Institute (NCI) to monitor cancer in the United States. The Surveillance, Epidemiology, and End Results (SEER) data system collects data on all cancers diagnosed among residents in geographically defined populations, which comprise about 10% of the U.S. population. This data system is the major component of the NCI system for tracking these rates. Thus, it is important to assess the degree to which SEER data are representative of the entire U.S. population. Purpose: National data on mortality, but not on incidence or survival, are available from the National Center for Health Statistics. These data provide a census against which mortality data from the subset of the SEER regions may be compared. Methods: Multivariate regression analyses of age-adjusted mortality rates from 1975 to 1988, computed for the SEER areas and for the entire United States, were performed for race- and sex-specific data from 15 cancer sites. Representativeness was evaluated by testing for differences in trends and levels between the data from the U.S. population and those from the SEER Program. Results: Data from the SEER regions reflected the correct direction of trend for all sites, although some race-, sex-, and site-specific differences existed for the magnitude of the trends and levels of mortality when compared with data from the U.S. population. Conclusions: The demonstration that data from the SEER population do occasionally yield mortality rates that differ from those for the entire U.S. population suggests that data from the SEER coverage population are, in some cases, not representative of the greater U.S. population. Implications: This issue is of particular relevance to the interpretation of incidence measures, computed from the SEER data, for which there is no national data-base. Future efforts should be directed at a better understanding of how the SEER population differs from the U.S. population so that SEER rates can be adjusted to be more nationally representative.
引用
收藏
页码:872 / 877
页数:6
相关论文
共 50 条
  • [1] ESTIMATING CANCER MORTALITY-RATES FROM SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER) PROGRAM INCIDENCE AND SURVIVAL-DATA
    CHU, KC
    SMART, CR
    HANKEY, BF
    HORM, JW
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (04) : 760 - 760
  • [2] Recent Time Trends in the Epidemiology of Stage IV Prostate Cancer in the United States: Analysis of Data From the Surveillance, Epidemiology, and End Results Program
    Cetin, Karynsa
    Beebe-Dimmer, Jennifer L.
    Fryzek, Jon P.
    Markus, Richard
    Carducci, Michael A.
    UROLOGY, 2010, 75 (06) : 1396 - 1404
  • [3] Representativeness of Participants in the Cancer Care Outcomes Research and Surveillance Consortium Relative to the Surveillance, Epidemiology, and End Results Program
    Catalano, Paul J.
    Ayanian, John Z.
    Weeks, Jane C.
    Kahn, Katherine L.
    Landrum, Mary Beth
    Zaslavsky, Alan M.
    Lee, Jeannette
    Pendergast, Jane
    Harrington, David P.
    MEDICAL CARE, 2013, 51 (02) : E9 - E15
  • [4] Recent Time Trends in the Epidemiology of Stage IV Prostate Cancer in the United States: Analysis of Data From the Surveillance, Epidemiology, and End Results Program REPLY
    Cetin, Karynsa
    Beebe-Dimmer, Jennifer
    Fryzek, Jon P.
    Markus, Richard
    Carducci, Michael A.
    UROLOGY, 2010, 75 (06) : 1404 - 1405
  • [5] MULTINATIONAL TRENDS IN CANCER MORTALITY-RATES - METHODOLOGICAL ISSUES AND RESULTS
    SCHWARTZ, J
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 609 : 136 - 145
  • [6] RECENT TRENDS IN REPORTED CIRRHOSIS MORTALITY-RATES
    KAELBER, C
    MALIN, H
    MUNCH, N
    HOLLAND, W
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1980, 4 (02) : 219 - 219
  • [7] TRENDS IN CANCER SURVIVAL AND MORTALITY-RATES
    PONTEN, J
    ADAMI, HO
    SPAREN, P
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1991, 8 (03): : 147 - 153
  • [8] Projecting prostate cancer incidence & mortality trends using the Surveillance, Epidemiology and End Results (SEER) data.
    Sarma, AV
    Schottenfeld, D
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (11) : s15 - s15
  • [9] Incidence and mortality trends of metastatic prostate cancer: Surveillance, Epidemiology, and End Results database analysis
    Zhang, Aaron C.
    Rasul, Rehana
    Golden, Anne
    Feuerstein, Michael A.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2021, 15 (12): : E637 - E643
  • [10] OVARIAN-CANCER IN THE ELDERLY - AN ANALYSIS OF SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM DATA
    YANCIK, R
    RIES, LG
    YATES, JW
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 154 (03) : 639 - 647